^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Marginal Zone Lymphoma |
| Drug: | Zevalin (ibritumomab tiuxetan) (CD20 inhibitor, Ionizing radiation emitter) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
Marginal Zone Lymphomas...Other Recommended Regimens...Ibritumomab
